Security key
88338N107
- Security type / class
- Equity / COM
- Total 13F shares
- 188,901,090
- Total 13F value
- $489,428,303
- Share change
- +669,942
- Put/Call ratio
- 234%
- SEC-reported price per share
- $2.60
- Number of holders
- 144
- Value change
- -$20,791,317
- Number of buys
- 79
- Number of sells
- 45
Open additional details 1 more signal available
Report period
Q2 2019
Institutions
144
Top holders
10
TXMD full security history
Ownership snapshot
Full 13F holder table
TherapeuticsMD, Inc. SEC filings
TherapeuticsMD, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of TXMD - THERAPEUTICSMD INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Bank of New York Mellon Corp
Disclosed value leader
Bank of New York Mellon Corp
Comparable rows
0/15
Latest evidence
31 Mar 2019
13F
Highest disclosed value: $117,585,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Bank of New York Mellon Corp has the largest disclosed position value at $117.58M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Bank of New York Mellon Corp's linked filing trail.
Disclosed position value
Top 5
Bank of New York Mellon Corp
$117.58M
PRICE T ROWE ASSOCIATES INC /MD/
$107.15M
JPMORGAN CHASE & CO
$99.52M
FMR LLC
$88.53M
BlackRock Finance, Inc.
$75.07M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Bank of New York Mellon Corp |
13F
Company
|
—
class O/S missing
|
$117,585,000
24,144,626 shares
|
— | 31 Mar 2019 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
—
class O/S missing
|
$107,150,000
22,002,036 shares
|
— | 31 Mar 2019 |
| JPMORGAN CHASE & CO |
13F
Company
|
—
class O/S missing
|
$99,521,000
20,435,672 shares
|
— | 31 Mar 2019 |
| FMR LLC |
13F
Company
|
—
class O/S missing
|
$88,527,000
18,178,211 shares
|
— | 31 Mar 2019 |
| BlackRock Finance, Inc. |
13F
Company
|
—
class O/S missing
|
$75,069,000
15,414,537 shares
|
— | 31 Mar 2019 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$67,081,000
13,774,222 shares
|
— | 31 Mar 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
144
Shares
188,901,090
Rows available
144
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2019 vs Q1 2019 Across Filers
Q1 2019 holders
139
Q2 2019 holders
144
Holder diff
5
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 value | Q2 2019 value | Value change | Value Chg % |
|---|